TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $173K of Entrada Therapeutics, Inc.
Sold$172,562
$19.98Price
8,637Shares
−10%Stake
What TRDA did after the filing
- The stock from Wed, Nov 13 close, $19.96
- −12.8%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Dec 27 close.
Traded Mon, Nov 11. Filed Wed, Nov 13, 11:47 AM ET, during the session. Returns use the Nov 13 close and the Dec 27 close. Not investment advice.